AKT1 and neoplasm: Dose-dependent reduction in proliferation and viability of PaCa-2 and Huh7 tumor cell lines via lowering of mRNA METTL3 level.Its mechanism is associated with PI3K/Akt/mTOR, Wnt/b-catenin, and MAPK/ERK1/2 pathways.